Alison Mack | Dec 8, 1996 | 8 min read
Sidebar: Further Information - Companies Creating Antisense Drugs BROADENED FOCUS: Shaji George says an equal number of biologists and chemists make up Innovir Laboratories' research team. Embracing the idea that tomorrow's drugs will not merely treat symptoms, but also attack disease-causing genes, scores of biotechnology companies are developing compounds to intervene in the cell's genetic machinery. One focus of this activity is antisense therapeutics: the use of synthetic nucleic acids de